Abstract
Biotechnology Law ReportVol. 42, No. 2 The Holman ReportA 2023 Review of Legislation Aimed at Increasing Generic and Biosimilar CompetitionBy Christopher M. HolmanBy Christopher M. HolmanChristopher M. Holman is a Professor of Law at the University of Missouri–Kansas City School of Law; a Senior Scholar at the Center for the Protection of Intellectual Property at the Antonin Scalia Law School, George Mason University; and the Executive Editor of Biotechnology Law Report.Search for more papers by this authorPublished Online:6 Apr 2023https://doi.org/10.1089/blr.2023.29303.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 2Apr 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:By Christopher M. Holman.A 2023 Review of Legislation Aimed at Increasing Generic and Biosimilar Competition.Biotechnology Law Report.Apr 2023.68-83.http://doi.org/10.1089/blr.2023.29303.cmhPublished in Volume: 42 Issue 2: April 6, 2023PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
